The Dopamine D2 Receptor Regulates the Development of Dopaminergic Neurons via Extracellular Signal-Regulated Kinase and Nurr1 Activation by �씠醫낆�
Neurobiology of Disease
The Dopamine D2 Receptor Regulates the Development of
Dopaminergic Neurons via Extracellular Signal-Regulated
Kinase and Nurr1 Activation
Sung Yul Kim,1* Kyou Chan Choi,1,2* Min Seok Chang,1Myoung Hwan Kim,1,2 Sa Yong Kim,1 Young-Soon Na,1
Jong Eun Lee,2 Byung Kwan Jin,3 Bong-Hee Lee,4 and Ja-Hyun Baik1
1School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, South Korea, 2Brain Korea 21 Project for Medical Science, College of Medicine,
Yonsei University, Seoul 120-752, South Korea, 3Neuroscience Graduate Program, Brain Disease Research Center, Ajou University School of Medicine,
Suwon 443-721, South Korea, and 4Department of Anatomy, Medical School, Cheju National University, Cheju 690-756, South Korea
Because the dopaminergic pathways in the midbrain have been closely associated with serious neuropsychiatric disorders, the elucida-
tion of the mechanisms underlying dopaminergic neuronal development should provide some important clues for related disorders. In
mice lacking the dopamine D2 receptor (D2R/), stereological cell counting analysis showed that the number of mesencephalic
tyrosine hydroxylase (TH) cells was significantly low during ontogeny, compared with that observed in wild-type (WT) mice, thereby
indicating an alteration in dopaminergic neuronal development in the absence of D2R. The results of immunohistochemical and reverse
transcription-PCR analyses revealed that the expression of Nurr1, an orphan nuclear receptor, as well as Ptx3 expression, was selectively
reduced in D2R/ mice during the embryonic stage. A reporter gene assay using the Nur response element linked to the luciferase
reporter gene indicated that the stimulation ofD2R results in the activation of theNurr1-mediated reporter gene. ThisD2R-mediatedNur
response element-dependent transcriptional activity was regulated via the activation of extracellular signal-regulated kinase (ERK).
Furthermore, quinpirole treatmentwas shown to elicit an increase in thenumberofTH-positiveneurons, aswell as theneuritic extension
ofTHneurons, coupledwithERKactivationandNurr1activation in theTH-positiveneurons inprimarymesencephalic cultures fromWT
mice. However, this regulation was not detected in the D2R/mice. These results suggest that signaling through D2R in association
with Nurr1 using ERK, plays a critical role in mesencephalic dopaminergic neuronal development.
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Introduction
Dopamine-producing cells are generated within the embryonic
ventral midbrain, and this process has been shown to require a
complex network consisting of a host of transcription factors and
signaling pathways (Perrone-Capano et al., 2000; Riddle and Pol-
lock, 2003; Simon et al., 2003). Because the dopaminergic path-
ways in the midbrain have been closely associated with serious
neuropsychiatric disorders, the elucidation of the mechanisms
underlying dopaminergic neuronal development should provide
some important clues as to possible treatments for related disor-
ders. Transcription factors including Ptx3 (paired-like home-
odomain transcription factor 3 or pituitary homeobox 3) and the
nuclear orphan receptor Nurr1 have been demonstrated to play a
critical role in dopaminergic neuronal development (Perrone-
Capano and Di Porzio, 2000; Perlmann and Wallen-Mackenzie,
2004). However, despite a variety of interesting findings, many
components of the networking of signaling pathways remain to
be found, and the mechanisms underlying the development of
dopaminergic neurons remain a matter for additional study.
Dopamine has been found to regulate neuronal development
via dopamine receptors (Todd, 1992; Schmidt et al., 1996). In
previous studies, dopamine has been reported to increase neu-
ritic elongation in embryonic rat cortical neurons via the activa-
tion of D2-like receptors (Todd, 1992). However, dopamine can
also inhibit growth cone motility and neurite outgrowth in avian
retinal neurons via the stimulation of D1-like receptors (Lank-
ford et al., 1988). Therefore, depending on the receptor type and
probably also on the signaling pathway exploited, the dopami-
nergic regulation of neuronal development appears to occur in a
variety of ways. However, the molecular mechanisms underlying
such dopamine receptor-induced regulation have yet to be clearly
elucidated.
To better characterize the role of dopamine in neuronal de-
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velopment, occurring via dopamine receptors, and specifically
the D2 receptor (D2R), we attempted to determine themanner in
which an absence of D2R affects dopaminergic neuronal develop-
ment in mice lacking the D2 receptor (D2R/) (Baik et al.,
1995; Usiello et al., 2000). We determined that, in the absence of
D2R, dopaminergic neuronal development was blunted in asso-
ciation with altered Nurr1 and Ptx3 expression in these mice.We
also demonstrated that D2R interacts withNurr1 via extracellular
signal-regulated kinase (ERK) signaling and that D2R-mediated
signaling is critical for the activation of Nurr1 and for dopami-
nergic neuronal development.
Materials andMethods
Animal preparation andmesencephalic neuronal cell culture.TheD2R/
mice and wild-type (WT) littermates originated from the mating of het-
erozygous of D2R/mice, identified by Southern hybridization anal-
yses as described previously (An et al., 2004). Insemination was con-
firmed by vaginal plug and considered to be embryonic day 0 (E0).
Pregnant mothers were killed in accordance with Society for Neuro-
science guidelines at E14. To prepare primary mesencephalic neuronal
cultures, the mesencephalon dissected from 14 d gestation mouse em-
bryo was incubated with 0.1% of trypsin in HBSS for 10 min at 37°C and
triturated with a constricted Pasteur pipette in high-glucose DMEMme-
dia supplemented with 10% FBS (Invitrogen, San Diego, CA), 1.4 mM
L-glutamine, and 6.0 g/L glucose. DA neurons were plated at 1.0  105
cells per 18  18 mm coverslip (Marienfeld, Lauda-Konigshofen, Ger-
many) or 2.0  105 cells per six-well plates precoated with 50 g/ml
poly-D-lysine and 2 g/ml laminin (Sigma, St. Louis, MO). DA neurons
were maintained at 37°C in a humidified 5%CO2 atmosphere in Neuro-
basal media supplemented with B27 and GlutaMax-1. At 5 d in vitro, the
DAneurons were incubatedwithNeurobasalmedia without B27 supple-
ment and treatedwith various experimental reagents for the time periods
indicated. 1-Methyl-4-phenylpyridinium (MPP) (Research Biochem-
ical, Natick, MA) was dissolved in culture medium and added at the
concentration specified for 24 h.
DA neurons were treated with 1 M quinpirole every 12 h in the
presence and absence of 1 M haloperidol or pretreated 50 M 2-(2-
amino-3-methoxyphenyl)-4H-1-benzopyran-4-one (PD98059) for the
duration of the experiment.
Immunocytochemistry and dual fluorescent staining. DA neurons were
fixed with 4% paraformaldehyde for 20 min at room temperature (RT)
and blocked for 1 h in PBS containing 5% normal horse serum and 0.2%
Triton X-100. Then the neurons were incubated with a rabbit polyclonal
anti-tyrosine hydroxylase (TH) (1:1000; Pel-Freez, Rogers, AR) in PBS
containing 1% normal horse serum and 0.2% Triton X-100 at 4°C over-
night, and followed by staining according to avidin–biotin immunohis-
tochemical procedures (Vector Laboratories, Burlingame, CA). Using a
microscope, cell counts weremade in randomly selected unbiased count-
ing frames (40 frames out of 81 grid were counted). Average length of
neurite in TH-positive neurons was analyzed under a microscope
equipped with MetaMorph imaging system (Universal Imaging Corpo-
ration, West Chester, PA) in 20 randomly selected fields (10 objective)
per each slide. A neurite lengthwas defined as the distance from the soma
to the tip of the longest branch. Average length of neurite represented the
divided value of total neurite length to the number of neurites per cell.
The neurites shorter than 10 m were excluded from morphometric
analysis.
For dual fluorescence labeling, fixed cells were incubated a rabbit poly-
clonal anti-TH (1:1000; Pel-Freez) and a mouse monoclonal anti-
phosphorylated ERK (p-ERK) (E10; 1:200; Cell Signaling, Beverly, MA),
or a mouse monoclonal anti-TH (1:1000; Diasorin, Stillwater, MN) and
a rabbit polyclonal anti-Nurr1 (M-196; 1:200; SantaCruz Biotechnology,
Santa Cruz, CA) at 4°C overnight. After washes with PBS containing
0.2% Triton X-100, the DA neurons were incubated at RT for 1 h with
Alexa Fluor 568 goat anti-rabbit IgG and Alexa Fluor 488 goat anti-
mouse IgG (1:200; Invitrogen, Eugene, OR) for a double localization of
TH and p-ERK, or TH and Nurr1 in PBS containing 1% normal horse
serum and 0.2% Triton X-100. As a negative control, the DA neurons
were incubated with the secondary antibody only. p-Erk-positive or
Nurr1-positive neurons amongTH-positive neuronswere examined un-
der an Axiovert 200 microscope equipped with epifluorescence unit and
Axiocam Digital Camera (Zeiss, Zena, Germany) and analyzed under a
real-time confocal microscope system with Nikon Eclipse fluorescence
microscope (TE2000-U; Nikon, Kanagawa, Japan) and Ultraview RS
confocal scanner (PerkinElmer, Wellesley, MA). Confocal fluorescence
image (20 objective) stimulated by 488 and 568 nm laser was filtered by
green emission filter and red/blue dual-emission filter, respectively. Co-
localization of Nurr1-positive cells among TH-positive neurons were
scored by examining 200 TH-positive neurons from randomly ac-
quired neuronal images (10 objective) in each condition. DA neurons
prepared from more than six embryos of wild and D2R/ genotypes
were analyzed in each condition.
Western blot analysis of p-ERK. After treatment with 10 M quinpirole
for 15min in the presence and absence of PD98059 (50M for 30min) or
haloperidol (1M for 5min), the DA neurons were washed with ice-cold
PBS and lysed in a buffer containing 20mMTris, pH 7.5, 150mMNaCl, 1
mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM glycerol
phosphate, 1 mM Na3VO4, 1 g/ml aprotinin, 1 g/ml leupeptin, 1 mM
PMSF, and 1% Triton X-100 for 10 min on ice. Cells were homogenized
with probe type sonicator on ice, and followed by centrifugation at
13,000 g for 10 min at 4°C. Protein (50 g) was separated on a 10%
SDS-PAGE, blotted onto prewetted polyvinylidene difluoride nitrocellu-
losemembrane. Primary antibodies usedwere amousemonoclonal anti-
p-ERK (1:2000; Cell Signaling) and a rabbit monoclonal anti-ERK (1:
5000; Santa Cruz Biotechnology). Specific bands were detected by
enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ)
and analyzed by LAS3000 image analysis system (Fuji, Tokyo, Japan).
Immunohistochemistry. For immunohistochemical studies, the heads
of wild-type and D2R/mouse embryos (E14) were fixed in 4% para-
formaldehyde for overnight at 4°C and soaked in 20% sucrose for 24–48
h. In the case of postnatal day 30 (P30) stage mice, the mice were tran-
scardially perfused with 4% paraformaldehyde. The brains were post-
fixed with fixative and kept in 30% sucrose for 24–48 h. Free-floating
cryostat sections (40 m) were serially prepared for TH and Nurr1 im-
munohistochemistry. Sections were washed in 0.1 M PBS, pH 7.4, three
times for 10 min and then placed in 0.1 M PBS solution containing 0.3%
H2O2 and 50%methanol for 30min. Sections were incubated in a block-
ing solution (0.2% Triton X-100, 1% BSA in 0.1 M PBS) for 30 min and
then overnight in primary antibody (rabbit anti-TH; 1:1000; Pel-Freez;
rabbit anti-Nurr1;M-196; 1:100; Santa Cruz Biotechnology) at 4°C. This
was followed by incubations at room temperature in biotinylated sec-
ondary antibody (anti-rabbit IgG; 1:500; Vector Laboratories) for 30
min, and then inABCkit (Vector Laboratories) for 30min. Sectionswere
then reacted with DAB (Vector Laboratories). PBS (0.1 M) rinses (three
times for 10 min) were performed between each step. Sections were
mounted, dehydrated, and coverslipped.
Stereological cell counts. The unbiased stereological estimation of the
total number of the TH-positive and Nurr1-positive cells in the substan-
tia nigra (SN) and ventral tegmental area (VTA) was made using the
optical fractionator (West, 1993). The Computer-Assisted Stereological
Toolbox system, version 2.1.4 (Olympus, Ballerup, Denmark) equipped
with anOlympus BX51microscope, amotorizedmicroscope stage (Prior
Scientific, Rockland, MA) run by an IBM-compatible computer, and a
microcator (Heidenhain ND 281B) connected to the stage and feeding
the computer with the distance information in the z-axis was used. The
borders of the SN at all levels in the rostocaudal axis were defined. The
medial border was defined by a vertical line passing through the medial
tip of the cerebral peduncle, by the medial terminal nucleus of the acces-
sory nucleus of the optic tract for excluding the TH-positive cells in the
VTA. The ventral border followed the dorsal border of the cerebral pe-
duncle, including the TH-positive cells in the pars reticulata, and the area
extended laterally to include the pars lateralis in addition to the pars
compacta. The sections used for counting covered the entire SN from the
rostral tip of the pars compacta back to the caudal end of the pars reticu-
lata (anterioposterior,2.06 to4.16 mm from bregma) (Paxinos and
Franklin, 2001). The SN or VTA was delineated at a 1.25 objective and
generated counting grid of 150 150 m. An unbiased counting frame
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of known area (47.87  36.19 m  1733 m2) superimposed on the
image was placed randomly on the first counting area and systemically
moved through all counting areas until the entire delineated area was
sampled. Actual counting was performed using a 100 oil objective. The
estimate of the total number of neurons was calculated according to the
optical fractionator formula (West, 1993). More than total 300 points
over all sections of each specimen were analyzed. Counting parameters
for E14 mouse embryonic brain differed slightly from those set for P30
mouse brain. Because of the size of SN and VTA, the counting grid was
reduced to 100  100 m. Counts represent the total value combined
both of hemispheres. The volumes of SN and VTA were also analyzed by
the method of Cavalieri’s principle (Gundersen et al., 1998), and no
considerable changes between WT and D2R/mice were observed.
Luciferase reporter gene assay. Human embryonic kidney 293
(HEK293) cells were grown in DMEM (Invitrogen) with 10% fetal bo-
vine serum and transfected with dopamine receptors, Nurr1, and Nur
response element (NurRE) using jetPEI transfection reagent (QBiogene,
Carlsbad, CA) by the procedure recommended by the manufacturer.
Briefly, 5–7  105 cells confluent monolayers of HEK293 cells were
transfectedwith 1.5g of pSV-D2Ror pSV-D1R, 1.5g of pCMX-Nurr1,
1.5g of pXP1-luc containing POMC gene promoter and three copies of
the NurRE (pXP1-NurRE-luc), and 0.5 g of pCH110. In case of the
transfection with Ras dominant-negative mutant, cells were transfected
with 1.0 g of pMT-RasN17 or pSK-null vector, 1.0 g of pSV-D2R, 1.0
g of pCMX-Nurr1, 1.0g of pXP1-NurRE-luc, and 0.5g of pCH110.
After 3 h, the transfection mixture was replaced with fresh growth me-
dium. Assays were performed 48 h after transfection. Cells were preincu-
bated overnight in serum-free growth medium before treatment with
agonists. The cells were treated with various concentrations of dopamine
or []-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1-H-3-
benzazepine hydrobromide (SKF81297), respectively, for 6 h at 37°C
with or without preincubation of haloperidol (1M for 5 min), pertussis
toxin (PTX) (100 ng/ml for 12 h),N-[2-( p-bromocinnamyl-amino)eth-
yl]-5-isoquinolinesulfonamide (H-89) (1 M for 20 min), and PD98059
(10 M for 30 min). After treatment, the cells were lysed and assayed for
luciferase activity using the luciferase assay system (Promega, Madison,
WI), and luminescence was measured using a 96-well luminometer (Mi-
crolumat; EG & Berthold, BadWilbad, Germany). The expression of the
reporter gene was normalized using -galactosidase activity. Results are
expressed as the ratio of luciferase activity of the transfected cells to that
of the unstimulated control. The mean values of the data obtained were
fitted to a sigmoid curve with a variable slope factor using nonlinear
squares regression in GraphPad Prism software.
Reverse transcription-PCR analysis. Total RNA was prepared from iso-
lated mesencephalon of mice brain using LiCl RNA extraction buffer.
First-strand cDNAs were generated from total RNA using reverse tran-
scriptionwith randomprimer by denaturing at 90°C for 4min, annealing
at room temperature for 10 min, and extending at 42°C for 50 min. The
following primers were used to amplify target cDNA: PTX3, 5-
AGGACGGCTCTCTGAAGAA-3, 5-TTGACCGAGTTGAAGGCGAA-
3; -actin, 5-GATGACGATATCGCTGCGCT-3, 5-GCTCATTG
CCGATAGTGATGACCT-3. Conditions for PCR amplifications were as
follows: 94°C for 5min, 30 cycles at 94°C for 1min, 60°C for 1min, 72°C for
1min, and final extension at 72°C for 7min. The PCRproductswere run on
1.5% agarose gels containing ethidium bromide (0.5 g/ml), to mark and
visualize the PCR products.
Statistical analysis. For statistical analyses, a two-sample comparison
was performed using Student’s t test, and multiple comparisons were
made using one-way ANOVA followed by appropriate post hoc
comparisons.
Results
Reduced numbers of dopaminergic neurons and vulnerability
to neurotoxin in D2R/mice
To determine whether the absence of D2Rmight affect the devel-
opment of dopaminergic neurons, we initially conducted a com-
parison of the numbers of dopaminergic neurons in the mesen-
cephalic neuronal cultures of WT and D2R/ mice embryos.
We measured the basal numbers of TH-immunoreactive neu-
rons in both WT and D2R/mice, and surprisingly, the num-
ber of detected TH-immunoreactive neurons was substantially
lower in the D2R/ mice than in the WT mice, having been
reduced to 65% of the number of TH-positive neurons ob-
served in the WT mice (Fig. 1). Because the overall numbers of
mesencephalic neurons are similar in theWT and D2R/mice
(data not shown), it appears likely that the absence of D2R exerts
a specific influence on the dopaminergic neurons.
To determinewhether the absence ofD2Rmight also affect the
survival of the mesencephalic dopaminergic neurons, we admin-
istered MPP to the primary mesencephalic dopaminergic neu-
ronal cultures from theWTandD2R/mice, at concentrations
ranging from 1 to 10 M (Fig. 1). In mesencephalic cultures of
D2R/mice, treatment with 10 M MPP
 resulted in a more
significant loss of dopaminergic neurons as was observed in the
cultures from WT mice (Fig. 1B). At a concentration of 10 M,
MPP reduced the number of surviving TH-immunoreactive
neurons to54% of control levels in the WTmice, and by up to
40% in the D2R/ mice (27% of control from WT) (Fig. 1B;
supplemental Fig. 1, available at www.jneurosci.org as supple-
mental material). Therefore, the effects of MPP were stronger
in the mesencephalic cultures from D2R/ mice than in the
WT mice, thereby suggesting that, in the absence of D2R, dopa-
minergic neurons become more susceptible to MPP toxicity.
Thus, in the absence of D2R, the number of dopaminergic neu-
rons is clearly reduced, and D2R appears to be also important for
dopaminergic neuronal survival.
Reduced TH, Nurr1, and Ptx3 expression in D2R/
mice embryos
We next assessed TH expression in the WT and D2R/ mice
embryos, in the substantia nigra and the ventral tegmental re-
Figure 1. TH-positive cells in mesencephalic cultures fromWT and D2R/ E14 mice and
the numbers of TH-positive cells after treatment with MPP. A, Representative photomicro-
graph of wild-type control (CT), D2R/ control, WT exposed to 10M MPP
 for 24 h, and
D2R/ exposed to 10M MPP
 for 24 h. Scale bar, 50m. B, Percentage of number of
TH-positive cells frommesencephalic cultures fromWT (n 5) and D2R/ (n 7) embry-
onic mice after treatment with 1–10M MPP. The data are presented as the mean SEM.
***p	 0.001 represents the result of paired Student’s t test for control versus MPP-treated
cells. ††p	 0.01 and †††p	 0.001 represent the result of unpaired Student’s t test for WT
versus D2R/mice.
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gions. Stereological counts of the TH-
positive neurons in the brain sections from
E14 of the WT and D2R/ embryos in-
dicated that the number of TH-expressing
cells was significantly reduced in the ven-
tral tegmentum and SN of D2R/ mice
(70% of WT mice) (Fig. 2A). These find-
ings strongly suggest that D2R plays an im-
portant role in the development of mesen-
cephalic dopaminergic neurons. In mice
aged 1 month (P30), stereological cell
counting analysis revealed that the num-
ber of TH neurons was still lower in the
D2R/ mice than in the WT mice, by
62% in SN region and 54% in VTA re-
gion (Fig. 2A). Therefore, the absence of
D2R appears to influence the dopaminer-
gic neuronal development.
The expression levels of the two tran-
scription factors, Nurr1 and Ptx3, were
also analyzed in WT and D2R/ mice
during development. Nurr1, an orphan
nuclear receptor, is expressed in the ven-
tral midbrains of mice before the appear-
ance of TH, and its expression continues in
the mature dopaminergic neurons during
adulthood. Ptx3, a homeodomain tran-
scription factor, is expressed uniquely in
the dopaminergic neurons of the substan-
tia nigra pars compacta and the ventral
tegmental region (Perrone-Capano andDi
Porzio, 2000; Riddle and Pollock, 2003).
Immunohistochemical and stereologi-
cal analysis indicated that Nurr1 expres-
sion had decreased significantly in
D2R/mice in the embryonic stage, to
70% of the levels measured in the WT
mice (Fig. 2B). In mice aged 1 month
(P30), the number of Nurr1-labeling
cells in the D2R/ mice was still re-
duced, showing 86% of the number
of Nurr1-labeling cells of WT mice
(Fig. 2B).
The Ptx3 expression level was also de-
creased in the D2R/ mice, which ex-
hibited a Ptx3 expression level of 70%
that of theWTmice, and this decrease per-
sisted throughout development in the
D2R/mice (Fig. 3).
D2R-mediated Nurr1 activation
Because the expression of both TH and
Nurr1had been reduced in the D2R/
mice, we hypothesized that D2R might
play a critical role in this regulation. We
first attempted to determine whether D2R
stimulation might induce Nurr1 activa-
tion. We conducted a NurRE-dependent
reporter gene activation assay on D2R ac-
tivation, by transfecting Nurr1 and D2R
into HEK293T cells, coupled with the
NurRE-Luc construct, a luciferase re-
porter gene driven by the POMC pro-
Figure 2. Stereological analysis of number of TH- and Nurr1-positive cells in WT and D2R/ mice. A, The sections were
prepared fromWT and D2R/ at E14 and P30 stages, respectively. Representative coronal sectionswith TH-positive cells in SN
and VTA visualized by immunohistochemistry are shown. Scale bar, 300m. TH-positive cells in themesencephalon of E14 stage
mice and in the SN and VTA of P30 stagemice are counted using stereological methods involving an optical fractionator. The data
(n 5 for E14; n 3 for P30) are presented as themean SEM. †p	 0.05 represents the result of unpaired Student’s t test for
WT versus D2R/mice. B, Representative coronal sections with Nurr1-positive cells in SN and VTA visualized by immunohis-
tochemistry are shown. Scale bars: left panels, 400 m; right panels, 200 m. Relative number of Nurr1-positive cells in the
mesencephalon of E14 stage mice and P30 stage mice are counted using stereological methods as mentioned in Materials and
Methods. The data (n 3 for E14; n 4 for P30) are presented as the mean SEM.
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moter containing NurRE (Philips et al., 1997a,b; Maira et al.,
1999).
Dopamine treatment elicited a dose-dependent luciferase ac-
tivation, indicating that D2R stimulation induced the activation
of Nurr1 and NurRE-dependent transcription, resulting in an
increase by 80% compared with the control levels (Fig. 4A). In
the absence of either D2R orNurr1, reporter gene activity was not
induced after dopamine stimulation. Treatment with haloperi-
dol, a D2R antagonist, completely blocked this dopamine-
induced NurRE-dependent transcriptional increase, thereby in-
dicating that this transactivation ofNurr1 ismediated specifically
by D2R (Fig. 4B). The D2R-mediated stimulation of NurRE ac-
tivity was also blocked by PTX, showing that D2R-mediated sig-
naling is crucial for the activation of Nurr1 (Fig. 4C).
Nurr1 activation has been reported to be dependent on the
activation of protein kinase A (PKA) and ERK (Kovalovsky et al.,
2002). BecauseD2R-mediated signalings also exploit these signal-
ing pathways (Choi et al., 1999; Kim et al., 2004), we analyzed the
involvement of PKA and ERK activation in D2R-mediated
NurRE-dependent transactivation. As is shown in Figure 4D,
D2R-mediated NurRE-dependent transcription was blocked
completely by the administration of the mitogen-activated pro-
tein (MAP) kinase kinase inhibitor, PD98059, thereby indicating
that this signaling is dependent on the ERK pathway. Because
D2R is known to use Ras-ERK signaling, we attempted to charac-
terize the role of Ras in D2R-mediated NurRE-dependent trans-
activation. As is shown in Figure 4E, the expression of the
dominant-negative mutant form of Ras, RasN17, resulted in a
significant inhibition of D2R-mediated NurRE-dependent tran-
scription. These results demonstrate that the regulation ofNurRE
activity exerted by dopamine D2R is controlled by the ERK
pathway.
By way of contrast, treatment with the PKA inhibitor, H-89,
had no effect on D2R-mediated NurRE activity (Fig. 4F). Other
dopamine receptor subtypes, including D1R, did not induce re-
porter gene activity under identical experimental conditions (Fig.
4G). Therefore, our data strongly indicated that D2R specifically
activates Nurr1, via ERK signaling.
Effect of a D2R agonist on dopaminergic neuronal
development in primary mesencephalic cultures
To determine whether D2R-induced ERK signaling and Nurr1
activation could be correlatedwith the role of D2R in dopaminer-
gic neuronal development, we attempted to characterize the di-
rect effects of a D2R agonist on the dopaminergic neurons and on
signaling occurring in the primary mesencephalic cultures. Pri-
mary mesencephalic cultures from WT and D2R/mice were
prepared and treated with quinpirole for 4 d. After 4 d of culture,
the cells were fixed and the TH-positive cells were counted. In the
mesencephalic primary cultures fromWTmice, quinpirole treat-
ment was shown to have increased the number of TH neurons by
20%, but this effect was not detected in the cultures from
D2R/mice (Fig. 5A,C). We also determined that quinpirole
treatment induced morphogenic effects, resulting in the neuritic
extension of the dopaminergic neurons. Quinpirole treatment
Figure 3. Developmental expression of Ptx3 mRNA in WT and D2R/ mice via reverse
transcription (RT)-PCR analysis.A, RT-PCR analysis for Ptx3 transcriptswas conducted at various
developmental stages from the midbrains of WT and D2R/ mice. The developmental
stages analyzed were E15, P1, M (1, 2, 4, 6 months), and Y (1 year). B, Data were plotted in
percentages for Ptx3 mRNA levels, respectively, in relation to the mRNA levels of the -actin
gene, which was used as an internal standard. The data (n 4) are presented as the mean
SEM. †p	 0.05 and ††p	 0.01 represent the result of unpaired Student’s t test for WT versus
D2R/mice.
Figure 4. NurRE-dependent transcriptional activation of the luciferase reporter gene after
D2R stimulation in HEK293T cells. A, HEK293T cells were transiently transfected with either a
combination of D2R and Nurr1 or Nurr1/D2R alone, followed by D2R stimulation with various
dopamine concentrations. B, C, Effects of the haloperidol (1M) (B) and effect of the PTX (100
ng/ml for 12 h) (C) on the D2R-mediated NurRE-dependent transcriptional activation of the
reporter gene.D–F, Effect ofMAP kinase kinase inhibitor PD98059 (10Mpreincubation for 30
min before the dopamine stimulation) (D), of RasN17 expression (E), and of PKA inhibitor H-89
(1Mpreincubation for 20min before the dopamine stimulation) (F ) on theNurRE-dependent
transcriptional activation of the luciferase reporter gene after D2R stimulation.G, Similar exper-
iments were conducted with the dopamine D1 receptor. HEK293T cells were transiently trans-
fected with either a combination of D1R and Nurr1 or with Nurr1/D1R alone, followed by D1
receptor stimulation with various dopamine concentrations. Data are expressed as the
means SEM from at least five independent experiments.
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induced an increase in the average length of the neurites and the
arborization of neuronal processes, as shown in Figure 5,A (panel
Q in WT) and C.
To confirm that the observed effects of quinpirole occurred
specifically via D2R, we administered haloperidol to quinpirole-
treated mesencephalic neurons. As shown in Figure 6, haloperi-
dol treatment completely blocked the effects of quinpirole in
mesencephalic neuronal cultures from WT mice, whereas halo-
peridol induced no changes with regard to both the number of
TH-positive neurons (Fig. 5B) and neuritic extension (Fig. 5C) in
the cultures from D2R/mice. Therefore, as we had hypothe-
sized, D2R-mediated signalings can play a critical role in mesen-
cephalic dopaminergic neuronal development, and in the ab-
sence of D2R, this regulation was blunted.
We then attempted to ascertain whether or not the D2R-
mediated enhancement of dopaminergic neuronal development
involves the ERK pathway, by treating the mesencephalic neu-
rons with the MEK (MAP kinase kinase) inhibitor, PD98059.
PD98059 treatment was shown to prevent the quinpirole-
induced increase of TH-positive neurons, and also resulted in a
reduction in the number of TH-positive neurons by 80% of con-
trol levels in the WT mice. However, no such significant differ-
ence was observed in the cultures from the D2R/ mice (Fig.
5A,B). Also, the average length of neurites was reduced in the
mesencephalic TH neurons in cultures from the WT mice as the
result of PD98059 treatment. The effects of quinpirole on the TH
neurons in cultures fromWTmice were blunted by cotreatment
with PD98059 (Fig. 5A,C). By way of contrast, the effects of
quinpirole with regard to the neuritic extension of dopaminergic
neurons were not affected significantly by additional PD98059
treatment in cultures from the D2R/ mice (Fig. 5C). These
findings demonstrated that dopamine-induced dopaminergic
neuronal development depends on the presence of the D2 recep-
tor and on the ERK pathway.
We then investigated whether or not quinpirole treatment
induced the activation of ERK and Nurr1 in the dopaminergic
mesencephalic neurons. As shown in Figure 6A, quinpirole treat-
ment induced ERK activation in the TH-positive neurons of WT
mice, but this activation was not detected in D2R/ mice, as
evidenced by the results of double immunofluorocytochemical
analysis coupled with confocal microscopy. This quinpirole-
induced activation of ERK was also detected viaWestern analysis
from quinpirole-treated primary cultures ofWTmice, but not in
cultures of D2R/ mice under identical conditions (Fig. 6B).
Quantitative analysis revealed that quinpirole treatment induced
an140% increase in ERK activation compared with the control
cells (Fig. 6C). These results show that ERK activation occurs in
response to D2R stimulation in mesencephalic dopaminergic
neurons and that, without D2R, ERK signaling is hardly detect-
able in the TH-positive neurons.
We also attempted to determine whether D2R activation
might induce Nurr1 activation in the dopaminergic neurons, via
the double-immunofluorescent labeling of Nurr1 and TH, fol-
lowed by confocal microscopic analysis. When we compared the
levels of Nurr1 expression in the TH-positive cells from the con-
trol mesencephalic neuronal cultures of WT and D2R/mice,
we found that the relative ratios for the Nurr1–TH-positive cell
populations were significantly lower in the mesencephalic cul-
tures from D2R/mice (Fig. 7A,B). In the WT mice, after 6 h
of quinpirole treatment under our experimental conditions, we
observed a pronounced augmentation in the percentage of
Nurr1–TH colocalization, with a concomitant increase in Nurr1
expression, compared with what was observed in the control cells
Figure 5. Dopamine D2R stimulation increases the number of TH neurons and enhances
morphological changes in the cultured mesencephalic neurons. A, Treatment with quinpirole
(Q), haloperidol plus quinpirole (HQ), PD98059 (PD), and PD98059 plus quinpirole (PDQ),
with a control group (CT) on themesencephalic neuronal cultures fromWTandD2R/mice.
The TH neurons were visualized via immunohistochemistry. Scale bars, 50 m. B, Effect of
treatmentwithquinpirole (Q), haloperidol plus quinpirole (HQ), PD98059 (PD), andPD98059
plus quinpirole (PDQ), with control group (CT) on the numbers of TH-positive neurons in
mesencephalic neuronal cultures from WT and D2R/ mice. C, Effects of treatment with
quinpirole (Q), haloperidol plus quinpirole (HQ), PD98059 (PD), or PD98059 plus quinpirole
(PDQ),with control group (CT) on theaverage lengthof theneurites of TH-positiveneurons in
mesencephalic neuronal cultures from WT and D2R/ mice. The mean values SEM are
shown for WT, n 5, and D2R/, n 5. *p	 0.05; ***p	 0.001; ANOVA followed by a
Newman–Keuls test for control versus drug-treated cells. †p	 0.05 and †††p	 0.001 repre-
sent the result of unpaired Student’s t test for WT and D2R/mice.
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(Fig. 7A,B). However, we detected no
changes in Nurr1 expression and no sig-
nificant Nurr1–TH colocalized cells in the
mesencephalic cultures from D2R/
mice counterparts (Fig. 7A,B). We at-
tempted to analyze the relative ratios of the
presence of Nurr1–TH colocalized cells af-
ter quinpirole treatment and found that
the treatment induced a75% increase in
the number of Nurr1–TH colocalized cells
in the treated TH neurons from WT mice
but exerted no detectable effects in TH
neurons from D2R/ mice (Fig. 7B).
These findings provide strong evidence
that D2R stimulation selectively employs
ERK signaling and Nurr1 activation in the
mesencephalic dopaminergic neurons and
that these signalings might play critical
roles in the D2R-mediated control of do-
paminergic neuronal development.
Discussion
In the present study, we determined that
the dopamine D2R plays a crucial role in
the development of dopaminergic neu-
rons, via the ERK pathway and the activa-
tion of Nurr1. As a result of these findings,
we suggest a new connection, in which do-
paminergic neurons activate ERK signaling
via mesencephalic dopamine receptors,
which in turn activates the transcription fac-
tor, Nurr1, a prerequisite for the develop-
ment of dopaminergic neurons (supple-
mental Fig. 2, available atwww.jneurosci.org
as supplemental material).
The dopamine D2R is known to be a
principal subtype of dopamine receptor,
which is first expressed in the mesenceph-
alon around E12 or earlier [The Gene Ex-
pression Nervous System Atlas Project;
http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?dbgensat&doptcmdlDetail&term
7245] (Macket al., 1991).ThedopamineD2-
like receptors have been suggested to be in-
volved inavarietyof importantmodulations
of mesencephalic dopaminergic cell func-
tion (Groves et al., 1975; Meiergerd et al.,
1993; Swarzenski et al., 1994; Cragg and
Greenfield, 1997).DopamineD2Rexpressed
in the midbrain during the embryonic stage
thus may function as a dopaminotrophic
factor, which facilitates the maintenance of
the secure development of dopaminergic
neurons during this critical period.
The loss of autoreceptor functions in
D2R/ mice has been demonstrated
previously (Mercuri et al., 1997). Our ob-
servations are consistent with several re-
ports that the D2-like receptors may play a
critical role in the dopaminergic neuronal
development. The D2-like receptors have
been theorized to play specific roles in the
regulation of the neuronal morphogenesis
Figure 6. ERK activation induced by dopamine D2R stimulation in mesencephalic dopaminergic neurons from WT and
D2R/ mice. A, Representative immunofluorescence images on the effects of quinpirole treatment on the colocalization of
p-ERK and TH-positive neurons fromWT and D2R/mice. Mesencephalic cultures fromWT and D2R/mice were treated
with quinpirole (Q), after which the cells were fixed and immunostained with anti-TH antibody and phospho-ERK antibody.
Colocalization of p-ERK immunoreactivitywithin TH-positive neuronswasmarkedby an arrowhead.B,C, RepresentativeWestern
blot and quantitative relative intensity analysis fromWestern blot analyses of phospho-ERK and total ERK levels ofmesencephalic
neuronal cells from WT and D2R/ mice. The cells were treated as follows: CT, control; Q, 10M quinpirole; HQ, 10M
quinpirole with 1 M haloperidol; PD, 50 M PD98059; PDQ, 10 M quinpirole preincubated with 50 M PD98059. Data
represent themean SEM frommore than four independent experiments. ***p	 0.001, ANOVA followedby aNewman–Keuls
test for control versus drug-treated cells. †p	 0.05 and ††p	 0.01 represent the result of unpaired Student’s t test betweenWT
and D2R/mice.
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of dopaminergic pathways (Swarzenski et
al., 1994; Guo et al., 2002; Wang et al.,
2004). Recently, theD2-like receptors have
also been suggested to play a role in the
modulation of adult neurogenesis (Ho-
glinger et al., 2004), as evidenced by obser-
vations of the dopaminergic regulation of
neural precursor cell proliferation via D2-
like receptors occurring in the adult mam-
malian brain. It is, therefore, somewhat
tempting to speculate that dopamine em-
ploys specific signaling, via D2-like recep-
tors, to control the development of dopa-
minergic neurons not only during
embryonic stages, but also during adult
neurogenesis.
In this study, our stereological cell
counting analyses of dopaminergic neuro-
nal cells permitted us to measure the dif-
ferences in the numbers of TH-positive
cells in both WT and D2R/ mice. In-
deed, it is actually fairly difficult to charac-
terize the differences in actual neuronal
cell numbers by conventional analyses,
which compare positive immunoreactive
cells or radiolabeled cells on a planar basis
in sectioned samples, rather than taking
the three-dimensional aspects of the brain
into account.
It has been suggested that the precise
anatomical localization and functional
differentiation of dopaminergic neurons
in the mammalian brain is achieved via
diffusible factors, including SHH (Sonic
Hedgehog) and FGF8 (fibroblast growth
factor), both of which constitute requisite
factors for dopaminergic neuronal induc-
tion (Hynes et al., 1995; Ye et al., 1998).
These factors appear to subsequently acti-
vate cascades of other signaling molecules
and transcription factors, resulting in the
final differentiation of the dopaminergic
neurons. Two transcription factors, Nurr1
and the homeodomain-related Ptx3, both
of which are expressed at crucial times in differentiating mid-
brain dopaminergic cells, have been identified, as has Limbx1, in
recent studies (Smidt et al., 1997, 2000; Zetterstro¨m et al., 1997;
Perrone-Capano et al., 2000). It has been consistently reported
that the absence ofNurr1 in knock-outmice resulted in the agen-
esis of dopaminergic neurons in the midbrain, and a consequent
lack of striatal dopamine innervation (Zetterstro¨m et al., 1997;
Castillo et al., 1998; Saucedo-Cardenas et al., 1998).
The mechanisms underlying the regulation of Nurr1 activity
during dopaminergic neuronal development have been exten-
sively studied. The majority of these studies, however, have been
rather tightly focused on the identification of Nurr1-regulating
factors, or on definitions of the manner in which Nurr1 is regu-
lated, to determine whether other signaling pathways use Nurr1
as a downstream target, because the ligand of this receptor has yet
to be identified. This study, however, may provide novel insight
into this puzzling aspect of Nurr1 regulation, by showing for the
first time the interactions and signaling pathways between dopa-
mine via D2R and Nurr1. Our results also point to cross talk
occurring between a nuclear receptor and a membrane receptor,
a fairly important aspect. Dopamine has previously been shown
to function as a physiological activator of the chicken ovalbumin
upstreampromoter transcription factor, amember of the orphan
steroid receptor family (Power et al., 1991). It has also been dem-
onstrated that the activation of dopaminergic pathways via D1-
like receptors might modulate reproductive behavior via the activa-
tion of progesterone receptors, in the absence of its cognate ligand
(Apostolakis et al., 1996).Oneof the keyobservationsof this paper is
that dopamine D2R functions as a potent Nurr1 activator, and we
were also able to define the role of ERK as an important signaling
mediator, linking D2R and Nurr1. Our observations indicate that
Nurr1 is certainly important with regard to the continued develop-
ment andmaintenance of dopaminergic cells during early develop-
ment but that thismaintenance is assured by the signalingmediated
bymesencephalic dopamine D2R.
It remains, however, to be explained how the development of
dopaminergic neurons can be tuned to a certain degree during
ontogeny, despite the initial severe perturbations associated with
Figure7. Colocalization of Nurr1with TH-positive neurons after D2R stimulation in themesencephalic neurons ofWTmice and
D2R/mice. Mesencephalic cultures fromWT and D2R/mice were treated with quinpirole for 6 h, after which the cells
were fixed and immunostained with anti-TH antibody and Nurr1 antibody. A, Representative immunofluorescence images by
confocal microscopic analysis, showing the effects of quinpirole (Q) treatment on the colocalization of Nurr1 and TH-positive
neurons fromtheWTandD2R/mice. ColocalizationofNurr1 immunoreactivitywithin TH-positiveneuronswasmarkedbyan
arrowhead. B, Quantitative analysis for the ratio of Nurr1-positive cells among the TH-positive neurons. Data are expressed as
meansSEM frommore than six independent experiments. **p	0.01 represents the result of pairedStudent’s t test for control
versus drug treated. †p	 0.05 and †††p	 0.001 represent the result of unpaired Student’s t test forWT versus D2R/mice.
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the expression of Nurr1 and TH. One possibility involves the
presence of another dopamine autoreceptor, D3, which appears
to serve similar functions during development, and then partially
compensates for Nurr1 expression at later stages of development.
Therefore, it will be necessary in the future to elucidate the presence
of other regulatory factors involved with the dopaminergic neurons
during critical developmental stages, and how they may be induced
from different environmental cues during development.
Ptx3 is induced at a later stage, and its expression in the brain
is confined to the dopaminergic neurons (Smidt et al., 1997; Bur-
bach et al., 2003). Ptx3 expression has been suggested to be inde-
pendent of Nurr1, and we also detected distinct expression Ptx3
regulation patterns, compared with those associated with Nurr1.
It has been recently reported that Wnt-5a induces an increase in
Ptx3 expression, and efficiently promotes the acquisition of a
dopaminergic phenotype in Nurr1-expressing precursors
(Castelo-Branco et al., 2003). In addition, van den Munckhof et
al. (2003) reported that Ptx3was a prerequisite formotor activity,
as well as for the survival of a subset of midbrain dopaminergic
neurons. Thus, it would be also interesting to determine whether
Ptx3 can still contribute to the survival of dopaminergic neurons
in D2R-deficient mice.
What is the role of Nurr1 in adult dopaminergic neurons, and
what impact can be imputed to the cross talk occurring between
D2R and Nurr1 in dopaminergic neurons of adult stage, assum-
ing it still occurs? Walle´n-Mackenzie et al. (2003) have proposed
that Nurr1 may promote neuronal survival, contributing to the
maintenance of mature dopaminergic neurons. Accordingly, the
dopaminergic neurons of Nurr1 heterozygous mice appear to be
more susceptible to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) (Le et al., 1999). This is consistent
with the observations made in this study, in which the dopami-
nergic neurons of D2R/ mice were found to exhibit elevated
susceptibility to neurotoxin MPTP because of the reduced ex-
pression of Nurr1 in these mice. Nurr1 may, then, promote the
survival of dopaminergic neurons in adultmice via similarmech-
anisms. It will be also challenging to explore the dopamine-
associated regulation of the molecular interaction of Nurr1 with
other binding partners, including the retinoid X receptor, in this
context.
In conclusion, the findings of this study provide us with new
insights into the network inherent to the development of dopa-
minergic neurons, with interactions occurring between the mes-
encephalic dopamine D2R and the orphan nuclear receptor,
Nurr1. Additional studies should attempt to determine whether
our findings represent a unique circuit for the homeostatic regu-
lation of dopaminergic neuronal development or whether they
can be generalized, for example, to mature dopaminergic neu-
rons, in which Nurr1 may contribute to the survival of mature
dopaminergic cells in vivo. Our findings should also be applied to
other situations in which neural plasticity would be required to
cope with novel environments, including stress and drug addic-
tion (Bannon et al., 2002), both of which have been linked to
neurological and psychiatric disorders involving the dopaminer-
gic neurotransmission system.
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